Bots, editor, reviewer, Administrators
13,941
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 4,887: | Line 4,887: | ||
}, | }, | ||
{ | { | ||
"timestamp" : "2024-04- | "timestamp" : "2024-04-02T17:35:36Z", | ||
"briefDesignDescription" : "ARB vs. B-blocker in HTN with LVH", | "briefDesignDescription" : "ARB vs. B-blocker in HTN with LVH", | ||
"fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)08089-3/abstract", | "fulltexturl" : "http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)08089-3/abstract", | ||
| Line 4,896: | Line 4,896: | ||
"subspecialties" : "Nephrology", | "subspecialties" : "Nephrology", | ||
"expansion" : "Cardiovvascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol", | "expansion" : "Cardiovvascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol", | ||
"statusUsableDate" : " | "statusUsableDate" : "2024-03-29", | ||
"briefResultsDescription" : "Losartan lowers stroke, MI, or CVD mortality vs. atenolol in HTN with LVH", | "briefResultsDescription" : "Losartan lowers stroke, MI, or CVD mortality vs. atenolol in HTN with LVH", | ||
"published" : "2002-03-23", | "published" : "2002-03-23", | ||